Current results as reference for future improvements in immunosuppression

The immunosuppressive drug regimen most commonly used for kidney transplant recipients during the last 10 years was a combination of cyclosporine with either steroids or azathioprine, or both. More recently, new immunosuppressive drugs, such as tacrolimus, mycophenolate and rapamycin have been intro...

Full description

Saved in:
Bibliographic Details
Main Authors: Opelz, Gerhard (Author) , Döhler, Bernd (Author) , Wujciak, Thomas (Author)
Format: Chapter/Article Conference Paper
Language:English
Published: 1999
In: Immunosuppression under trial
Year: 1999, Pages: 3-9
DOI:10.1007/978-94-011-4643-2_1
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/978-94-011-4643-2_1
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/chapter/10.1007/978-94-011-4643-2_1
Get full text
Author Notes:G. Opelz, B. Döhler and T. Wujciak

MARC

LEADER 00000caa a22000002c 4500
001 1748708171
003 DE-627
005 20230427070954.0
007 cr uuu---uuuuu
008 210219s1999 xx |||||o 00| ||eng c
024 7 |a 10.1007/978-94-011-4643-2_1  |2 doi 
035 |a (DE-627)1748708171 
035 |a (DE-599)KXP1748708171 
035 |a (OCoLC)1341395397 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Opelz, Gerhard  |d 1944-  |e VerfasserIn  |0 (DE-588)1026480345  |0 (DE-627)726772453  |0 (DE-576)371826527  |4 aut 
245 1 0 |a Current results as reference for future improvements in immunosuppression  |c G. Opelz, B. Döhler and T. Wujciak 
264 1 |c 1999 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.02.2021 
520 |a The immunosuppressive drug regimen most commonly used for kidney transplant recipients during the last 10 years was a combination of cyclosporine with either steroids or azathioprine, or both. More recently, new immunosuppressive drugs, such as tacrolimus, mycophenolate and rapamycin have been introduced and hopes were raised that these new medications would improve the success rate of kidney grafts. Experience with these new drugs is still limited and long-term follow up is currently not available. The present report provides an overview of results obtained with regimens that were considered `standard’ during the last 10 years. They should serve as a reference against which future improvements can be measured. 
650 4 |a Immunosuppressive drug 
650 4 |a Kidney transplant recipient 
650 4 |a Graft survival rate 
650 4 |a Steroid withdrawal 
650 4 |a Maintenance regimen 
700 1 |a Döhler, Bernd  |e VerfasserIn  |0 (DE-588)1121948634  |0 (DE-627)875040691  |0 (DE-576)481065997  |4 aut 
700 1 |a Wujciak, Thomas  |e VerfasserIn  |0 (DE-588)1147593604  |0 (DE-627)1006343601  |0 (DE-576)495883867  |4 aut 
773 0 8 |i Enthalten in  |t Immunosuppression under trial  |d Dordrecht : Springer, 1999  |g (1999), Seite 3-9  |h Online-Ressource (IX, 179 p.)  |w (DE-627)749095326  |w (DE-576)9749095324  |z 9789401146432  |7 nnam  |a Current results as reference for future improvements in immunosuppression 
773 1 8 |g year:1999  |g pages:3-9  |g extent:7  |a Current results as reference for future improvements in immunosuppression 
856 4 0 |u https://doi.org/10.1007/978-94-011-4643-2_1  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://link.springer.com/chapter/10.1007/978-94-011-4643-2_1  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210219 
993 |a ConferencePaper 
994 |a 1999 
998 |g 1147593604  |a Wujciak, Thomas  |m 1147593604:Wujciak, Thomas  |d 910000  |d 911600  |e 910000PW1147593604  |e 911600PW1147593604  |k 0/910000/  |k 1/910000/911600/  |p 3  |y j 
998 |g 1121948634  |a Döhler, Bernd  |m 1121948634:Döhler, Bernd  |d 910000  |d 911600  |e 910000PD1121948634  |e 911600PD1121948634  |k 0/910000/  |k 1/910000/911600/  |p 2 
998 |g 1026480345  |a Opelz, Gerhard  |m 1026480345:Opelz, Gerhard  |d 910000  |d 911600  |e 910000PO1026480345  |e 911600PO1026480345  |k 0/910000/  |k 1/910000/911600/  |p 1  |x j 
999 |a KXP-PPN1748708171  |e 3864861055 
BIB |a Y 
JSO |a {"physDesc":[{"extent":"7 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource (IX, 179 p.)","noteIll":"digital"}],"name":{"displayForm":["edited by P. Cochat, J. Traeger, C. Merieux, M. Derchavane"]},"id":{"eki":["749095326"],"doi":["10.1007/978-94-011-4643-2"],"isbn":["9789401146432"]},"origin":[{"dateIssuedDisp":"1999","dateIssuedKey":"1999","publisher":"Springer","publisherPlace":"Dordrecht"}],"language":["eng"],"recId":"749095326","type":{"media":"Online-Ressource","bibl":"edited-book"},"disp":"Current results as reference for future improvements in immunosuppressionImmunosuppression under trial","part":{"text":"(1999), Seite 3-9","extent":"7","year":"1999","pages":"3-9"},"person":[{"given":"Pierre","family":"Cochat","role":"edt","roleDisplay":"Hrsg.","display":"Cochat, Pierre"},{"display":"Traeger, J.","role":"oth","family":"Traeger","given":"J."},{"given":"C.","family":"Merieux","role":"oth","display":"Merieux, C."},{"role":"oth","display":"Derchavane, M.","given":"M.","family":"Derchavane"}],"title":[{"title_sort":"Immunosuppression under trial","title":"Immunosuppression under trial","subtitle":"proceedings of the 31st Conference on Transplantation and Clinical Immunology, 3-4 June, 1999"}]}],"name":{"displayForm":["G. Opelz, B. Döhler and T. Wujciak"]},"origin":[{"dateIssuedKey":"1999","dateIssuedDisp":"1999"}],"id":{"eki":["1748708171"],"doi":["10.1007/978-94-011-4643-2_1"]},"type":{"bibl":"chapter","media":"Online-Ressource"},"note":["Gesehen am 19.02.2021"],"language":["eng"],"recId":"1748708171","person":[{"given":"Gerhard","family":"Opelz","role":"aut","roleDisplay":"VerfasserIn","display":"Opelz, Gerhard"},{"roleDisplay":"VerfasserIn","display":"Döhler, Bernd","role":"aut","family":"Döhler","given":"Bernd"},{"role":"aut","display":"Wujciak, Thomas","roleDisplay":"VerfasserIn","given":"Thomas","family":"Wujciak"}],"title":[{"title":"Current results as reference for future improvements in immunosuppression","title_sort":"Current results as reference for future improvements in immunosuppression"}]} 
SRT |a OPELZGERHACURRENTRES1999